ANAB vs AMGN: Which Stock is Better?

Side-by-side comparison of Anaptysbio Inc and Amgen Inc in 2026

Comparison Updated:

ANAB

Anaptysbio Inc

$55.67

AMGN

Amgen Inc

$336.79

Key Metrics Comparison

MetricANABAMGNWinner
Market Cap$1.69B$181.37BAMGN
P/E RatioN/A23.37AMGN
EPS (TTM)$N/A$14.38AMGN
Revenue Growth-0.1%0.1%AMGN
Gross Margin44.6%71.4%AMGN

Analyze ANAB

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ANAB or AMGN a better investment?

Comparing ANAB and AMGN: Anaptysbio Inc has a market cap of $1.69B while Amgen Inc has $181.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ANAB and AMGN?

ANAB (Anaptysbio Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ANAB or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ANAB or AMGN?

AMGN has higher revenue growth at 0.1% vs -0.1% for ANAB.

Which company is more profitable: ANAB or AMGN?

Amgen Inc (AMGN) has higher gross margins at 71.4% compared to 44.6% for ANAB.

Which is the larger company: ANAB or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $181.37B compared to $1.69B for ANAB.

Should I buy ANAB or AMGN in 2026?

Both ANAB and AMGN have investment merit. ANAB trades at $55.67 while AMGN trades at $336.79. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ANAB and AMGN stock?

Key differences: Market Cap ($1.69B vs $181.37B), P/E Ratio (N/A vs 23.4x), Revenue Growth (-0.1% vs 0.1%), Gross Margin (44.6% vs 71.4%).

Popular Stock Comparisons